PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers). PreDxion Bio is backed by Y Combinator, Invest Detroit, and angel investors, and has received funding from the NIH. PreDxion Bio has been granted an FDA Breakthrough Device Designation for the development of our core localized surface plasmon resonance (LSPR) biosensor technology.
View Top Employees from Refractal| Website | http://www.refractal.com |
| Revenue | $4.4 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2017 |
| Address | 329 Oyster Point Blvd FL 3, South San Francisco, California 94080, US |
| Phone | (978) 777-5500 |
| Fax | (978) 777-6575 |
| Industry | Wellness and Fitness Services, Business Services General, Business Services |
| SIC | SIC Code 594 Companies, SIC Code 59 Companies, SIC Code 5944 Companies |
| NAICS | NAICS Code 44831 Companies, NAICS Code 448 Companies, NAICS Code 44 Companies, NAICS Code 4483 Companies |
Looking for a particular Refractal employee's phone or email?
Refractal Questions
The Refractal annual revenue was $4.4 million in 2023.
Walker McHugh is the CEO of Refractal.
2 people are employed at Refractal.
Refractal is based in South San Francisco, California.
The NAICS codes for Refractal are [44831, 448, 44, 4483].
The SIC codes for Refractal are [594, 59, 5944].
Top Refractal Employees
Related Companies
